Ukraine Pharma - New Opportunities for Growth

Ukraine Pharma - New Opportunities for Growth

According to “Ukraine Pharma - New Opportunities for Growth”, a new research report by RNCOS, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In 2007, the Ukrainian pharmaceutical market grew by nearly 21% to register revenues in excess of US$ 2 Billion. The market is characterized by an increasing proportion of imported and high-priced drugs. In 2007, the average unit price of drugs sold in Ukraine increased by nearly 20%, strongly pushing the value of pharmaceutical sales, despite a relatively ordinary growth in sales volume.

The future outlook of the industry also seems very positive as the market is expected to be driven by a number of reforms recently proposed by the government. Factors such as increasing penetration of health insurance and increasing disposable incomes of consumers will also fuel growth. The lack of effective price controls and high margins are also expected to lure foreign players in this market. The country’s unstable political environment, however, will be the biggest hurdle for investments. But overall, the market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012.

This report gives an extensive and objective analysis on the pharmaceutical market of Ukraine. It investigates both the past and present trends in the market, with its main focus on the future trends shaping the industry. The study discusses the performance of both the retail and hospital segments of the pharmaceutical market in detail and based on various present and future indicators, analyzes the future of these segments. This report gives valuable information to manufacturers/investors planning to enter the Ukrainian pharmaceutical market.

The Report Provides Forecasts on

• Macroeconomic Indicators
• Healthcare Indicators
• Population & Demographics
• Disease Profiles
• Total Pharmaceutical Market
• Retail Pharmaceutical Market
• Hospital Pharmaceutical Market

Key Player Profiling

“Ukraine Pharma - New Opportunities for Growth” provides brief profiling on key players, both domestic and foreign, currently operating in the Ukraine pharmaceutical market. This section describes the revenues and growth of players in the total pharmaceutical market, retail market and hospital market. Performance of key drugs in various segments of the market has also been evaluated. Business profiles of top five players, Berlin Chemie, Sanofi Aventis, Novartis, Arterium and Darnitsa, have also been discussed in this report.

1. Analyst View
2. What Makes Ukraine so Lucrative
2.1 Robust Economic Growth
2.2 Improved Investment Climate
2.3 Growth of High-priced Drugs
2.4 Healthcare Infrastructure
3. Population & Demographics
4. The Pharmaceutical Market
4.1 Market Size
4.2 Imported & Domestically Manufactured Drugs
4.3 Leading Domestic & Foreign Manufacturers
4.4 Leading Pharmaceutical Distributors
5. The Retail Market
5.1 Market Size
5.2 Prescription & OTC Sales
5.3 Therapeutic Segmentation
5.4 Leading Domestic & Foreign Players
5.5 Leading Drugs
5.6 Price Characteristics of Drug Consumption
6. The Hospital Market
6.1 Market Size
6.2 Prescription & OTC Sales
6.3 Therapeutic Segmentation
6.4 Leading Domestic & Foreign Players
6.5 Leading Drugs
6.6 Price Characteristics of Drug Consumption
7. Opportunities
7.1 Clinical Trials Market
7.2 Contract Manufacturing
7.3 Medical Devices Market
8. Roadblocks
8.1 Unstable Political Environment
8.2 Declining Population
8.3 Lack of Effective Reimbursement System
8.4 Opaque Tax System
9. Forecasts
9.1 Critical Success & Risk Factors Shaping the Future
9.1.1 Critical Success Factors
9.1.2 Critical Risk Factors
9.2 Pharmaceutical Market
9.2.1 Retail Market
9.2.2 Hospital Market
10. Key Company Profiles
10.1 Berlin-Chemie
10.2 Sanofi-Aventis Group
10.3 Novartis
10.4 Arterium
10.5 Darnitsa Pharma

List of Figures:

Figure 2-1: Ukraine - Nominal GDP (in Billion US$), 2001-2007 & 2012F
Figure 2-2: Ukraine - Disposable Income per Head (in US$), 2001-2007E & 2012F
Figure 2-3: Ukraine - Healthcare Expenditure per Head (in US$), 2001-2007E & 2012F
Figure 2-4: Ukraine - Hospital Beds (per ‘000 Population), 2001-2007E & 2012F
Figure 2-5: Ukraine - Doctors (per ‘000 Population), 2002-2007E & 2012F
Figure 3-1: Ukraine - Population (in Million), 2001-2007E & 2012F
Figure 3-2: Ukraine - Population Breakup by Age Group (%), 2005-2007E & 2012F
Figure 3-3: Ukraine - Leading Causes of Death (%), 2005
Figure 3-4: Ukraine - Deaths due to Leading Causes (in Number), 2005
Figure 3-5: Ukraine - Forecast for Leading Causes of Death (%), 2030
Figure 3-6: US - Forecast for Deaths due to Leading Causes (in Number), 2030
Figure 4-1: Ukraine - Pharmaceutical Market (in Million US$), 2006 & 2007
Figure 4-2: Ukraine - Pharmaceutical Market (in Million Units), 2006 & 2007
Figure 4-3: Ukraine - Proportion of Generic & Branded Drugs (%)
Figure 4-4: Ukraine - Share of Retail & Hospital Segment in Pharmaceutical Market by Sales Value (%), 2006 & 2007
Figure 4-5: Ukraine - Share of Retail & Hospital Segment in Pharmaceutical Market by Sales Volume (%), 2006 & 2007
Figure 4-6: Ukarine - Pharmaceutical Imports (in Billion US$), 2005-2007E
Figure 4-7: Ukarine - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market by Sales Value (%), 2006 & 2007E
Figure 4-8: Ukarine - Top 5 Pharmaceutical Importing Countries (in ‘000 Units) 2006 & 2007
Figure 5-1: Ukraine - Retail Pharmaceutical Market (in Million US$), 2006 & 2007
Figure 5-2: Ukraine - Retail Pharmaceutical Market (in Million Units), 2006 & 2007
Figure 5-3: Ukraine - Share of RX & OTC Drugs in Retail Pharmaceutical Market by Sales Value (%), 2006 & 2007
Figure 5-4: Ukraine - Share of RX & OTC Drugs in Retail Pharmaceutical Market by Sales Volume (%), 2006 & 2007
Figure 5-5: Ukraine - Retail Pharmaceutical Market by Therapeutic Area (%), 2007
Figure 6-1: Ukraine - Hospital Pharmaceutical Market (in Million US$), 2006 & 2007
Figure 6-2: Ukraine - Hospital Pharmaceutical Market (in Million Units), 2006 & 2007
Figure 6-3: Ukraine - Share of RX & OTC Drugs in Hospital Pharmaceutical Market by Sales Value (%), Q1-Q3 2007
Figure 6-4: Ukraine - Share of RX & OTC Drugs in Hospital Pharmaceutical Market by Sales Volume (%), Q1-Q3 2007
Figure 6-5: Ukraine - Hospital Pharmaceutical-Market by Therapeutic Area (%), Q1-Q3 2007
Figure 7-1: Ukraine - Medical Devices Market (in Million US$), 2007E & 2012F
Figure 9-1: Ukraine - Forecast for Pharmaceutical Market (in Million US$), 2008-2012
Figure 9-2: Ukraine - Forecast for Share of Retail & Hospital Segment in Pharmaceutical Market by Sales Value (%), 2008-2012
Figure 9-3: Ukraine - Forecast for Retail Pharmaceutical Market (in Million US$), 2008-2012
Figure 9-4: Ukraine - Forecast for Hospital Pharmaceutical Market (in Million US$), 2008-2012

List of Tables:

Table 2-1: Ukraine - Average Price per Trading Unit of Pharmaceuticals (in US$), 2006 & 2007
Table 2-2: Ukraine - Hospital Beds & Doctors w.r.t. Developed Countries (per ‘000 Population), 2007E
Table 4-1: Ukraine - Statistics of Top Players in Pharmaceutical Market (2007)
Table 4-2: Ukraine - Market Share of Top Pharmaceutical Distributors (%), 2006 & 2007
Table 5-1: Ukraine - Statistics of Top Players in Retail Pharmaceutical Market (2007)
Table 5-2: Ukraine - Statistics of Top 10 Drugs in Retail Pharmaceutical Market (2007)
Table 5-3: Ukraine - Price Characteristics of Drug Consumption in Retail Pharmaceutical Market
Table 6-1: Ukraine - Statistics of Top Players in Hospital Pharmaceutical Market (2007)
Table 6-2: Ukraine - Statistics of Top 20 Drugs in Hospital Pharmaceutical Market (Q1-Q3 2007)
Table 6-3: Ukraine - Average Retail Price per Drug in Hospital Pharmaceutical Market (in US$), Q1-Q3 2006 & Q1-Q3 2007
Table 9-1: Ukraine - Critical Sucess Factors for Pharmaceutical Market
Table 9-2: Ukraine - Critical Risk Factors for Pharmaceutical Market